Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for myocardial injury improvement after primary PCI in STEMI
IRCT20240323061353N1Phase 3Completed
- Sponsor
- Baqiyatallah University of Medical Sciences
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in myocardial infarction (MI) comparing Pentoxifylline with Placebo (2 arms). Primary endpoints: Troponin I, Creatine phosphokinase and 2 more. Started Jun 2024; status: completed.
02
Drugs
pentoxifylline
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on IRCT20240323061353N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240323061353N1.